NCT06357312 is a NA clinical trial of hip trochanteric nail in Hip Fracture, sponsored by Elda University Hospital.

Who is sponsoring NCT06357312?

NCT06357312 is sponsored by Elda University Hospital.

What drugs are being tested in NCT06357312?

Interventions in NCT06357312: hip trochanteric nail.

What condition does NCT06357312 study?

NCT06357312 studies Hip Fracture.

Is NCT06357312 still recruiting?

NCT06357312 is currently recruiting now. Last updated 10 April 2024.

Last reviewed 2024-04-10 · How we verify

NCT06357312

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Static Distal Locking of a Short Proximal Femoral Nail

Recruiting now NA Last updated 10 April 2024

What this trial tests

NA trial testing hip trochanteric nail in Hip Fracture in 200 participants. Currently enrolling.

Timeline

1 April 2024

Primary endpoint
1 April 2024

1 April 2024

Quick facts

Lead sponsor	Elda University Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	200
Start date	1 April 2024
Primary completion	1 April 2024
Estimated completion	1 April 2024
Sites	1 location across Spain

Drugs / interventions tested

hip trochanteric nail

Conditions studied

Hip Fracture — all drugs for Hip Fracture →

Sponsor

Elda University Hospital

Who can join

50 and older, any sex, with Hip Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, comparative, randomized, double-blind study to evaluate the outcomes of trochanteric nailing in unstable hip fractures with and without a distal interlocking screw.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hip Fracture

Currently open trials in the same condition.

NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
NCT07113483 — Remimazolam vs. Midazolam for Sedation and Cognitive Outcomes in Orthopedic Surgery · Phase 3 · recruiting
NCT06898814 — The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery · Phase 4 · recruiting
NCT06818409 — Is the CRP-Albumin-Lymphocyte (CALLY) Index Effective in Predicting Postoperative Delirium in Geriatric Patients Undergo · recruiting
NCT07202208 — Effectiveness of the Delirium Zero Protocol to Prevent the Onset of Delirium in Patients Undergoing Hip Fracture Surgery · NA · recruiting

Other Elda University Hospital trials

Trials by the same sponsor.

NCT05437822 — Tranexamic Acid in Proximal Humeral Fractures · Phase 4 · unknown
NCT04769544 — Comparison Between Medial Pivot Versus Symmetric Insert Total Knee Arthroplasty · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06357312 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Elda University Hospital
Last refreshed: 10 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06357312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing